Cisplatin
9 Inquiries
15663-27-1
2026-07-12
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionKeywords
Cisplatin
Cisplatin
Cisplatin
Quick DetailsProName:Cisplatin
CasNo:15663-27-1
Molecular Formula:Cl2H6N2Pt
Appearance:Yellow crystalline powder
Application:used in medicine
DeliveryTime:prompt shipment
PackAge:as required
Port:China main port
ProductionCapacity:1 Kilogram/Day
Purity:≥98.0%
Storage:Room temperature
Transportation:by sea by air express
LimitNum:0 Metric Ton
SuperiorityIt conforms to USP36
Details
Appearance
Yellow crystalline powder
HPLC
HPLC the retention time of the major peak corresponds to that of the standard sample.
IR
IR the infrared absorption spectrum exhibits maximum only at the same wavelengths as that of the standard sample.
TLC
TLC the principle spot corresponds in appearance and Rf to that of the standard sample.
Cystalline
Meets the requirements
Water content
≤1.0%
UV purity ratio
≥4.5
Trichloroamine-platinate
≤1.0%
Transplatin
≤2.0%
Platinum content
64.42%~65.22%
Assay
98.0% ～102.0%
Basic Info-
Product Name:
Cisplatin
Other Name:Platinum,diamminedichloro-,(SP-4-2)-;Platinum,diamminedichloro-,cis-;(SP-4-2)-Diamminedichloroplatinum;cis-Diamminedichloroplatinum;cis-Dichlorodiamineplatinum(II);cis-Platinum(II) diaminodichloride;cis-Platinum(II) diamminedichloride;cis-Dichlorodiammineplatinum;cis-Platinous diaminodichloride;cis-Platinum diaminodichloride;cis-Platinumdiammine dichloride;cis-Platinumdiamine dichloride;cis-Diaminodichloroplatinum(II);NSC 119875;Cisplatin;cis-Platinum II;Platinol;Neoplatin;cis-Platine;Biocisplatinum;cis-DDP;cis-Diamminedichloroplatinum(II);Platidiam;cis-Platinum;Cisplatinum;CPDD;cis-Platin;cis-Dichlorodiammineplatinum(II);TR 170;CDDP;DDP;CPPD;cis-Diaminedichloroplatinum(II);Cisplatyl;Briplatin;DDP (antitumor agent);Abiplatin;SPI 077;CACP;Lederplatin;Platosin;Platamine;Platiblastin;Platistin;Platinoxan;CPDC;Cismaplat;Citoplatino;Rand;Platinex;Platinol AQ;SPI 077 (complex);SPI 077B103;Cisplatino;Lipoplatin;Randa;Fauldiscipla;IA-call;CP Ethypharm;LiPlaCis;Cisplatine Mylan;Kemoplat;Citoplax;Maruko;cis-Diaminedichloridoplatinum(II);cis-Diammineplatinum(II);96081-74-2;936542-99-3
CAS No.:15663-27-1
Molecular Formula:Cl2H6N2Pt
InChIKeys:InChIKey=LXZZYRPGZAFOLE-UHFFFAOYSA-L
Molecular Weight:298.02900
Exact Mass:296.94000
UNII:Q20Q21Q62J|BW0OY6ZTD4
DSSTox ID:DTXSID50275807
NCI Thesaurus Code:C376
HScode:2932999099
Categories:
Characteristics-
PSA:
52.04000
XLogP3:2.02430
Density:4 x 10-6 g/cm3
Melting Point:270 °C (decomp)
Water Solubility:soluble in DMF. Insoluble in most common solvents<0.1 g/100 mL at 19 oC;Insoluble in water.
Storage Conditions:Store in a cool, dry, well-ventilated area away from incompatible substances. Poison room locked. Keep containers tightly closed
Toxicity:LD50 in guinea pigs: 9.7 mg/kg i.p. (Fleishman)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 2, Oral
Serious eye damage, Category 1
Carcinogenicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H300 Fatal if swallowed
H318 Causes serious eye damage
H350 May cause cancer
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History9 Inquiries
Country Product Purchase Quantity Date Posted 
India
Anti-Cancer Cisplatin CAS 15663-27-1 Cisplatin Powder 99% Purity Cisplatin
2 G Sep 29, 2023
India
CISPLATIN
50 MG Sep 1, 2025
India
CISPLATIN
1 KG Jul 8, 2024
India
Cisplatin
10 G Sep 28, 2023 
Pakistan
Cisplatin
1.00 KG May 8, 2026
Pakistan
Cisplatin
1.00 KG Jan 29, 2026 
Bangladesh
Cisplatin
25 KG Sep 23, 2025 
Japan
Cisplatin
100 G May 13, 2024 
Egypt
cisplatin
1 G Feb 7, 2024 Post an enquiry for this product
